Zacks Investment Research downgraded shares of SYNERON MED LTD (ELOS) from OUTPERFORM to NEUTRAL on February 08, 2013, with a target price of $11.20.
Syneron Medical Ltd. manufactures and distributes medical aesthetic devices that are powered by the proprietary, patented ELOS combined-energy technology of Bi-Polar Radio Frequency and Light. The Company's innovative ELOS technology provides the foundation for highly effective, safe and cost-effective systems that enable physicians to provide advanced solutions for a broad range of medical-aesthetic applications.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on SYNERON MED LTD (ELOS),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment